These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pollock-Barziv SM, Finkelstein Y, Manlhiot C, Dipchand AI, Hebert D, Ng VL, Solomon M, McCrindle BW, Grant D. Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278 [Abstract] [Full Text] [Related]
9. Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort study. Hiramitsu T, Tomosugi T, Futamura K, Okada M, Nishihira M, Goto N, Ichimori T, Narumi S, Kobayashi T, Uchida K, Watarai Y. Int Immunopharmacol; 2021 Feb; 91():107038. PubMed ID: 33388731 [Abstract] [Full Text] [Related]
12. Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients. Abu Bakar K, Mohamad NA, Hodi Z, McCulloch T, Williams A, Christian M, Key T, Kim JJ. Pediatr Nephrol; 2019 Dec; 34(12):2557-2562. PubMed ID: 31520127 [Abstract] [Full Text] [Related]
14. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level. Nair SS, Sarasamma S, Gracious N, George J, Anish TS, Radhakrishnan R. Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154 [Abstract] [Full Text] [Related]
15. The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation): Impact of the Concentration-Dose Ratio on Death-censored Graft Survival. Jouve T, Fonrose X, Noble J, Janbon B, Fiard G, Malvezzi P, Stanke-Labesque F, Rostaing L. Transplantation; 2020 Jun; 104(6):1263-1271. PubMed ID: 31415035 [Abstract] [Full Text] [Related]